Stryker Q3 FY25: where the revenue came from and where it went
The whole income statement of Stryker for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2025
- Reported
- Oct 31, 2025
Revenue$6.06B
+10% year over year
Gross profit$3.85B
64% margin
Operating profit$1.14B
19% margin
Net profit$0.86B
14% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 6.06 | 100% | +10% |
| Med surg & neurotechnology | 3.80 | 63% | |
| Orthopaedics & spine | 2.25 | 37% | |
| Cost of revenue | −2.21 | 36% | |
| Gross profit | 3.85 | 64% margin | +0pp |
| R&D | −0.41 | 7% | +0pp |
| SG&A | −2.05 | 34% | −1pp |
| Other | −0.26 | 4% | +0pp |
| Operating profit | 1.14 | 19% margin | −1pp |
| Interest & other costs | −0.11 | ||
| Tax | −0.17 | ||
| Net profit | 0.86 | 14% margin | −1pp |
209 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest